Howard Liebman, MD

Title(s)Professor of Medicine, Don Feinstein Chair in Hematology
SchoolKeck School of Medicine of Usc
Address1441 Eastlake Ave.
Health Sciences Campus
Los Angeles CA 90033
Phone+1 323 865 3950
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Keck School of MedicineMDMedical School, Doctor of Medicine
    LAC + USC Medical CenterInternship, Internal Medicine
    LAC + USC Medical CenterResidency, Internal Medicine
    LAC + USC Medical CenterFellowship, Hematology
    Tufts-New England Medical CenterFellowship in Immunochemistry and coagulation chemistry
    Collapse Awards and Honors
    American College of Physicians Fellow

    Collapse Overview 
    Collapse Overview
    Dr. Howard Liebman, Professor of Medicine and Pathology is the author or co-author of over 170 peer reviewed publications, review articles and chapters. He has presented over two hundred lectures across the United States, South America, Europe. Korea and Japan. He has served as the former Chair of the Massachusetts Governor's Task Force subcommittee on experimental therapies and clinical trials for AIDS. He is a medical advisor for the Platelet Disorder Support Association and a member of the Cancer and Thrombosis Guidelines Committee of the American Society of Clinical Oncology. He has served on several grant review committees for the National Institute of Health. He presently holds the Donald I Feinstein Endowed Chair of Hematology.

    In addition to his academic responsibilities, Dr. Liebman is an attending staff member of the LAC+USC Medical Center, the USC/Norris Comprehensive Cancer Center and the Keck Hospital of USC. Dr. Liebman also is on the forefront of research in thrombotic and hemorrhagic disorders. His lab is currently studying the genetic risk factors responsible for thrombotic diseases including venous thrombosis, pulmonary embolism, and arterial thrombosis. Dr. Liebman is also internationally known for his work in the relationships between venous thrombotic disease and underlying malignancy. He has been and is the principal investigator on several clinical trials in the management of immune thrombocytopenia (ITP). His research group has made important discoveries on the role of infectious agents in the development of immune thrombocytopenia and secondary ITP.

    Collapse Research 
    Collapse Research Activities and Funding
    ROLE OF METAL IONS IN THE FUNCTION OF HUMAN FACTOR IX
    NIH R29HL039665Feb 15, 1988 - Mar 1, 1994
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study. Ther Adv Hematol. 2023; 14:20406207231205431. Kuter DJ, Bussel JB, Ghanima W, Cooper N, Gernsheimer T, Lambert MP, Liebman HA, Tarantino MD, Lee M, Guo H, Daak A. PMID: 37869360; PMCID: PMC10585997.
      View in: PubMed   Mentions: 2  
    2. Complement in immune thrombocytopenia (ITP): The role of complement in refractory ITP. Br J Haematol. 2023 10; 203(1):96-100. Weitz IC, Liebman HA. PMID: 37735550.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    3. Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia. Res Pract Thromb Haemost. 2023 Mar; 7(3):100134. Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Bernheisel C, Wojdyla M, Vredenburg M, Cuker A. PMID: 37193124; PMCID: PMC10182312.
      View in: PubMed   Mentions: 4  
    4. The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, disseminated mycobacterium avium complex infection. Allergy Asthma Clin Immunol. 2022 Sep 09; 18(1):82. Boyle S, Hagiya A, Nguyen MH, Liebman H, Lee JSG. PMID: 36085248; PMCID: PMC9461271.
      View in: PubMed   Mentions: 2  
    5. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Blood. 2022 03 10; 139(10):1564-1574. Lee EJ, Beltrami-Moreira M, Al-Samkari H, Cuker A, DiRaimo J, Gernsheimer T, Kruse A, Kessler C, Kruse C, Leavitt AD, Lee AI, Liebman HA, Newland AC, Ray AE, Tarantino MD, Thachil J, Kuter DJ, Cines DB, Bussel JB. PMID: 34587251; PMCID: PMC8483984.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    6. Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study. Br J Haematol. 2022 05; 197(3):359-366. Al-Samkari H, Jiang D, Gernsheimer T, Liebman H, Lee S, Wojdyla M, Vredenburg M, Cuker A. PMID: 35179784; PMCID: PMC9306832.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    7. Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern. Res Pract Thromb Haemost. 2021 Aug; 5(6):e12592. Cuker A, Liebman HA. PMID: 34466771; PMCID: PMC8387601.
      View in: PubMed   Mentions: 8  
    8. Understanding Immune Thrombocytopenia: Looking Out of the Box. Front Med (Lausanne). 2021; 8:613192. Schifferli A, Cavalli F, Godeau B, Liebman HA, Recher M, Imbach P, Kühne T. PMID: 34249957; PMCID: PMC8266194.
      View in: PubMed   Mentions: 6  
    9. Nattokinase atherothrombotic prevention study: A randomized controlled trial. Clin Hemorheol Microcirc. 2021; 78(4):339-353. Hodis HN, Mack WJ, Meiselman HJ, Kalra V, Liebman H, Hwang-Levine J, Dustin L, Kono N, Mert M, Wenby RB, Huesca E, Rochanda L, Li Y, Yan M, St John JA, Whitfield L. PMID: 33843667.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    10. Are Tpo agonists an option for ITP in pregnancy? Blood. 2020 12 24; 136(26):2971-2972. Liebman HA. PMID: 33367548.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method. Res Pract Thromb Haemost. 2021 Jan; 5(1):69-80. Cuker A, Despotovic JM, Grace RF, Kruse C, Lambert MP, Liebman HA, Lyons RM, McCrae KR, Pullarkat V, Wasser JS, Beenhouwer D, Gibbs SN, Yermilov I, Broder MS. PMID: 33537531; PMCID: PMC7845076.
      View in: PubMed   Mentions: 7  
    12. Prediction and Prevention of Cancer-Associated Thromboembolism. Oncologist. 2021 01; 26(1):e2-e7. Khorana AA, DeSancho MT, Liebman H, Rosovsky R, Connors JM, Zwicker J. PMID: 33274815; PMCID: PMC7794203.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    13. Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review. EJHaem. 2020 Jul; 1(1):44-50. Hermel M, Hermel D, Azam S, Shinbane J, Sarcon A, Jones E, Mehta A, Grazette L, Liebman H, Weitz I. PMID: 35847716; PMCID: PMC9175940.
      View in: PubMed   Mentions: 1  
    14. Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia. Am J Hematol. 2020 02; 95(2):178-187. Newland AC, Sánchez-González B, Rejto L, Egyed M, Romanyuk N, Godar M, Verschueren K, Gandini D, Ulrichts P, Beauchamp J, Dreier T, Ward ES, Michel M, Liebman HA, de Haard H, Leupin N, Kuter DJ. PMID: 31821591; PMCID: PMC7004056.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    15. A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia. Hematology. 2019 Dec; 24(1):679-719. Newland A, Bentley R, Jakubowska A, Liebman H, Lorens J, Peck-Radosavljevic M, Taieb V, Takami A, Tateishi R, Younossi ZM. PMID: 31581933.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    16. A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia. Acta Haematol. 2020; 143(3):244-249. Piatek CI, Bocian H, Algaze S, Weitz IC, O'Connell C, Liebman HA. PMID: 31665725.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020 02 10; 38(5):496-520. Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A. PMID: 31381464.
      View in: PubMed   Mentions: 480     Fields:    Translation:Humans
    18. Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer. JCI Insight. 2019 02 21; 4(4). Zwicker JI, Schlechter BL, Stopa JD, Liebman HA, Aggarwal A, Puligandla M, Caughey T, Bauer KA, Kuemmerle N, Wong E, Wun T, McLaughlin M, Hidalgo M, Neuberg D, Furie B, Flaumenhaft R, CATIQ Investigators11. PMID: 30652973; PMCID: PMC6478409.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCTClinical Trials
    19. Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. N Engl J Med. 2019 02 21; 380(8):720-728. Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH, CASSINI Investigators. PMID: 30786186.
      View in: PubMed   Mentions: 260     Fields:    Translation:HumansCTClinical Trials
    20. Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk. Thromb Res. 2018 04; 164 Suppl 1:S19-S22. Liebman HA. PMID: 29703479.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Ethnic and racial difference in Helicobacter pylori infection in patients with immune thrombocytopenia treated at a major urban medical center. Platelets. 2019; 30(3):413-417. O'Neill CM, Weitz IC, O'Connell C, Liebman HA. PMID: 29580123.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    22. Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia. Platelets. 2019; 30(2):206-212. Garabet L, Ghanima W, Monceyron Jonassen C, Skov V, Holst R, Mowinckel MC, C Hasselbalch H, A Kruse T, Thomassen M, Liebman H, Bussel JB, Sandset PM. PMID: 29215956.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    23. Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort Study. JNCI Cancer Spectr. 2017 Sep; 1(1):pkx009. Sohal DPS, Kuderer NM, Shepherd FA, Pabinger I, Agnelli G, Liebman HA, Meyer G, Kalady MF, McCrae K, Lyman GH, Khorana AA. PMID: 31360835; PMCID: PMC6649852.
      View in: PubMed   Mentions: 2     Fields:    
    24. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK). Oncologist. 2018 02; 23(2):247-255. Kuderer NM, Poniewierski MS, Culakova E, Lyman GH, Khorana AA, Pabinger I, Agnelli G, Liebman HA, Vicaut E, Meyer G, Shepherd FA. PMID: 28951500; PMCID: PMC5813740.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    25. Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial. Thromb Haemost. 2017 11 01; 117(11):2135-2145. Khorana AA, Vadhan-Raj S, Kuderer NM, Wun T, Liebman H, Soff G, Belani C, O'Reilly EM, McBane R, Eikelboom J, Damaraju CV, Beyers K, Dietrich F, Kakkar AK, Riess H, Peixoto RD, Lyman GH. PMID: 28933799; PMCID: PMC6328370.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    26. Autoimmune Hemolytic Anemia. Med Clin North Am. 2017 Mar; 101(2):351-359. Liebman HA, Weitz IC. PMID: 28189175.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    27. Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia. Haematologica. 2016 11; 101(11):1327-1332. Liebman HA, Saleh MN, Bussel JB, Negrea OG, Horne H, Wegener WA, Goldenberg DM. PMID: 27515248; PMCID: PMC5394874.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    28. OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin. Thromb Res. 2016 Apr; 140 Suppl 1:S174. Piatek CI, Tagawa ST, Wei-Tsai D, Hanna D, Weitz IC, O'Connell C, Rochanda L, Groshen S, Liebman HA. PMID: 27161687.
      View in: PubMed   Mentions: 1     Fields:    
    29. Immune modulation for autoimmune disorders: evolution of therapeutics. Semin Hematol. 2016 04; 53 Suppl 1:S23-6. Liebman HA. PMID: 27312159.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    30. Incidental venous thromboembolic events in cancer patients: what we know in 2016. Thromb Res. 2016 Apr; 140 Suppl 1:S18-20. Liebman HA, O'Connell C. PMID: 27067973; PMCID: PMC9129141.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    31. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost. 2016 Jan; 14(1):105-13. van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M, Jiménez D, Portillo AK, O'Connell C, Liebman HA, Shteinberg M, Adir Y, Tiseo M, Bersanelli M, Abdel-Razeq HN, Mansour AH, Donnelly OG, Radhakrishna G, Ramasamy S, Bozas G, Maraveyas A, Shinagare AB, Hatabu H, Nishino M, Huisman MV, Klok FA. PMID: 26469193; PMCID: PMC7480998.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    32. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab. Transfusion. 2015 Oct; 55(10):2398-403. Boonyasampant M, Weitz IC, Kay B, Boonchalermvichian C, Liebman HA, Shulman IA. PMID: 25989361.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Management of immune-mediated cytopenias in pregnancy. Autoimmun Rev. 2015 Sep; 14(9):806-11. Piatek CI, El-Hemaidi I, Feinstein DI, Liebman HA, Akhtari M. PMID: 25981747.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH: reply. J Thromb Haemost. 2015 Jul; 13(7):1352-3. Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M. PMID: 25854143.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2015 May; 13(5):880-3. Di Nisio M, Lee AY, Carrier M, Liebman HA, Khorana AA, Subcommittee on Haemostasis and Malignancy. PMID: 25714858.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    36. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost. 2015 Apr; 13(4):671-5. Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M, Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. PMID: 25556711.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    37. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. J Clin Oncol. 2015 Feb 20; 33(6):654-6. Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A, American Society of Clinical Oncology. PMID: 25605844; PMCID: PMC4881372.
      View in: PubMed   Mentions: 269     Fields:    Translation:Humans
    38. Approach to the management of incidental venous thromboembolic events in patients with cancer. J Natl Compr Canc Netw. 2014 Nov; 12(11):1557-60. O'Connell CL, Liebman HA. PMID: 25361802.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Thrombocytopenia in cancer patients. Thromb Res. 2014 May; 133 Suppl 2:S63-9. Liebman HA. PMID: 24862148.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    40. Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials. Eur J Haematol. 2013 Nov; 91(5):423-36. Rodeghiero F, Stasi R, Giagounidis A, Viallard JF, Godeau B, Pabinger I, Cines D, Liebman H, Wang X, Woodard P. PMID: 23927437.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    41. Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. Br J Haematol. 2013 Sep; 162(5):693-701. Liebman HA, Saleh MN, Bussel JB, Negrea OG, Horne H, Wegener WA, Goldenberg DM. PMID: 23829485.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    42. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Jun 10; 31(17):2189-204. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A, American Society of Clinical Oncology Clinical Practice. PMID: 23669224.
      View in: PubMed   Mentions: 251     Fields:    Translation:Humans
    43. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood. 2013 Apr 04; 121(14):2596-606. Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, Cines DB, Cooper N, Godeau B, Greinacher A, Imbach P, Khellaf M, Klaassen RJ, Kühne T, Liebman H, Mazzucconi MG, Newland A, Pabinger I, Tosetto A, Stasi R. PMID: 23361904.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    44. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013 Mar; 128(3):544-51. Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman LD. PMID: 23262205.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    45. Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study). Br J Haematol. 2013 Feb; 160(4):530-7. Zwicker JI, Liebman HA, Bauer KA, Caughey T, Campigotto F, Rosovsky R, Mantha S, Kessler CM, Eneman J, Raghavan V, Lenz HJ, Bullock A, Buchbinder E, Neuberg D, Furie B. PMID: 23240761; PMCID: PMC3609903.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCellsCTClinical Trials
    46. Incidental venous thromboembolism in oncology patients. J Thromb Haemost. 2012 Dec; 10(12):2602-4. Khorana AA, O'Connell C, Agnelli G, Liebman HA, Lee AY, Subcommittee on Hemostasis and Malignancy of the SSC of the ISTH. PMID: 23362525; PMCID: PMC3561673.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    47. A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. J Thromb Haemost. 2012 May; 10(5):807-14. Levine MN, Gu C, Liebman HA, Escalante CP, Solymoss S, Deitchman D, Ramirez L, Julian J. PMID: 22409262.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCTClinical Trials
    48. Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation. Thromb Res. 2012 Sep; 130(3):361-8. Weitz IC, Razavi P, Rochanda L, Zwicker J, Furie B, Manly D, Mackman N, Green R, Liebman HA. PMID: 22542362.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    49. Treating venous thromboembolism in patients with cancer. Expert Rev Hematol. 2012 Apr; 5(2):201-9. Piatek C, O'Connell CL, Liebman HA. PMID: 22475288; PMCID: PMC4435973.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    50. Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism. J Clin Oncol. 2011 Nov 01; 29(31):4208-9; author reply 4209-10. O'Connell CL, Razavi PA, Liebman HA. PMID: 21969510.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Approach to the treatment, characterization and diagnosis of an acquired auto-antibody directed against factors prothrombin, factor X and factor IX: a case report and review of the literature. Haemophilia. 2012 Jan; 18(1):102-7. Rochanda L, Del Zoppo GJ, Feinstein DI, Liebman HA. PMID: 21707870.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost. 2011 Feb; 9(2):305-11. O'Connell C, Razavi P, Ghalichi M, Boyle S, Vasan S, Mark L, Caton A, Duddalwar V, Boswell W, Grabow K, Liebman HA. PMID: 20955348.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    53. Clinical roundtable monograph. The oncologist's role in management of venous thromboembolism. Clin Adv Hematol Oncol. 2011 Jan; 9(1):suppl 1-15. Liebman H, Khorana A, Kessler C. PMID: 21361081.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    54. Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Hematology Am Soc Hematol Educ Program. 2011; 2011:384-90. Liebman HA, Pullarkat V. PMID: 22160062.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    55. What do healthcare providers ask their patients with immune thrombocytopenia? Am J Hematol. 2010 Aug; 85(8):629-31. Rabin DU, Kuter DJ, Liebman HA, Bussel JB. PMID: 20658595.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Thyroid disease in patients with immune thrombocytopenia. Hematol Oncol Clin North Am. 2009 Dec; 23(6):1251-60. Cheung E, Liebman HA. PMID: 19932432.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    57. The immune thrombocytopenia syndrome: a disorder of diverse pathogenesis and clinical presentation. Hematol Oncol Clin North Am. 2009 Dec; 23(6):1155-61. Cines DB, Liebman HA. PMID: 19932425.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    58. Preface. Hematol Oncol Clin North Am. 2009 Dec; 23(6):xi. Liebman HA. PMID: 19932424.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009 Nov 15; 15(22):6830-40. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, Furie B. PMID: 19861441; PMCID: PMC2783253.
      View in: PubMed   Mentions: 166     Fields:    Translation:Humans
    60. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res. 2010 Jun; 125(6):511-2. Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key NS, Mackman N. PMID: 19854471; PMCID: PMC2878897.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    61. Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia. Biologics. 2009; 3:57-62. Cheung E, Liebman HA. PMID: 19707396; PMCID: PMC2726056.
      View in: PubMed   Mentions: 8  
    62. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009 Jun 25; 113(26):6511-21. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. PMID: 19395674; PMCID: PMC2710913.
      View in: PubMed   Mentions: 254     Fields:    Translation:HumansCellsPHPublic Health
    63. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders. Semin Hematol. 2009 Jan; 46(1 Suppl 2):S33-6. Liebman HA. PMID: 19245932.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    64. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009 Jan; 46(1 Suppl 2):S2-14. Cines DB, Liebman H, Stasi R. PMID: 19245930; PMCID: PMC2682438.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    65. Managing cancer-related venous thromboembolic disease: low-molecular-weight heparins and beyond. Expert Rev Hematol. 2008 Dec; 1(2):175-82. O'Connell CL, Liebman HA. PMID: 21082922.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    66. Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy. BJU Int. 2008 Nov; 102(9):1086-91. Tagawa ST, Dorff TB, Rochanda L, Ye W, Boyle S, Raghavan D, Lieskovsky G, Skinner DG, Quinn DI, Liebman HA. PMID: 18671791.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia. J Vasc Surg. 2008 Aug; 48(2):377-81. Alexy T, Tucker S, Boyle S, Rowe VL, Weaver FA, Liebman HA. PMID: 18515040.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Heparin-induced thrombocytopenia: diagnosis and management. Vascular. 2008 Mar-Apr; 16 Suppl 1:S71-6. Liebman HA. PMID: 18544310.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet. 2008 Feb 02; 371(9610):395-403. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL. PMID: 18242413.
      View in: PubMed   Mentions: 240     Fields:    Translation:Humans
    70. Viral-associated immune thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program. 2008; 212-8. Liebman HA. PMID: 19074085.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    71. Immune thrombocytopenia (ITP): an historical perspective. Hematology Am Soc Hematol Educ Program. 2008; 205. Liebman HA. PMID: 19074083.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007 Dec 01; 25(34):5490-505. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW, American Society of Clinical Oncology. PMID: 17968019.
      View in: PubMed   Mentions: 223     Fields:    Translation:Humans
    73. The role of oral anticoagulants in tumor biology. Semin Thromb Hemost. 2007 Oct; 33(7):695-8. Weitz IC, Liebman HA. PMID: 18000797.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    74. Other immune thrombocytopenias. Semin Hematol. 2007 Oct; 44(4 Suppl 5):S24-34. Liebman H. PMID: 18096469.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    75. Secondary immune thrombocytopenic purpura. Curr Opin Hematol. 2007 Sep; 14(5):557-73. Liebman HA, Stasi R. PMID: 17934365.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    76. A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP). Blood. 2007 Jun 15; 109(12):5527; author reply 5528. Tarantino MD, Bussel JB, Cines DB, McCrae KR, Gernsheimer T, Liebman HA, Wong WY, Kulkarni R, Grabowski E, McMillan R. PMID: 17554071.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    77. Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance. J Clin Oncol. 2006 Oct 20; 24(30):4928-32. O'Connell CL, Boswell WD, Duddalwar V, Caton A, Mark LS, Vigen C, Liebman HA. PMID: 17050877.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    78. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr. 2006 Aug 15; 42(5):572-7. Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. PMID: 16837864.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    79. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol. 2006 Feb; 33(2):355-7. Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. PMID: 16465669.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    80. Current perspectives on primary prophylaxis and patient risk factors for venous thromboembolism in the cancer patient. Cancer Control. 2005 Sep; 12 Suppl 1:11-6. Liebman HA. PMID: 16179899.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    81. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol. 2005 Jun; 129(6):818-24. Rajan SK, Espina BM, Liebman HA. PMID: 15953010.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    82. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. Leuk Res. 2005 Mar; 29(3):347-51. Tallman MS, Brenner B, Serna Jde L, Dombret H, Falanga A, Kwaan HC, Liebman H, Raffoux E, Rickles FR. PMID: 15661272.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    83. Subcutaneous lepirudin for heparin-induced thrombocytopenia and when other anticoagulants fail: illustrative cases. Clin Adv Hematol Oncol. 2004 Jun; 2(6):382-4; discussion 384-6. Deitcher SR, Ngengwe R, Kaplan R, Liebman H, Kaplan K, Blinder M. PMID: 16163209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol. 2003 Oct; 123(2):278-81. Ru X, Liebman HA. PMID: 14531909.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    85. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment. Am J Hematol. 2003 Jan; 72(1):43-52. Sutherland DE, Weitz IC, Liebman HA. PMID: 12508268.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    86. Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. Thromb Res. 2003; 111(4-5):235-8. Liebman HA, Feinstein DI. PMID: 14693169.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    87. Anticoagulation is an effective treatment for aortic mural thrombi. J Vasc Surg. 2002 Oct; 36(4):713-9. Bowdish ME, Weaver FA, Liebman HA, Rowe VL, Hood DB. PMID: 12368731.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    88. Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis. 2002 Oct; 61(10):922-4. Arzoo K, Sadeghi S, Liebman HA. PMID: 12228164; PMCID: PMC1753910.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    89. Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism. Br J Haematol. 2002 Sep; 118(4):1166-9. Pullarkat V, Ngo M, Iqbal S, Espina B, Liebman HA. PMID: 12199802.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    90. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation. Thromb Haemost. 2002 Aug; 88(2):213-20. Weitz IC, Israel VK, Waisman JR, Presant CA, Rochanda L, Liebman HA. PMID: 12195692.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    91. Treatment of hepatitis C related thrombocytopenia with interferon alpha. Am J Hematol. 2001 Nov; 68(3):202-9. Rajan S, Liebman HA. PMID: 11754404.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    92. Acquired bleeding disorder in a patient with malignant lymphoma: antibody-mediated prothrombin deficiency. Cancer. 2001 Feb 15; 91(4):636-41. Lee ES, Hibsman BK, Liebman HA. PMID: 11241228.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    93. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal Radiol. 2000 Oct; 29(10):563-71. Terk MR, Dardashti S, Liebman HA. PMID: 11127678.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    94. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII. Am J Hematol. 2000 Mar; 63(3):109-13. Liebman HA, Chediak J, Fink KI, Galvez AG, Shah PC, Sham RL. PMID: 10679799.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    95. Ticlopidine-induced aplastic anemia: development of chromosomal abnormalities and response to immunosuppressive therapy. Am J Hematol. 2000 Mar; 63(3):141-4. Pullarkat VA, Rho H, Murata-Collins JL, Liebman HA. PMID: 10679804.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    96. Three Gaucher-disease-producing mutations in a patient with Gaucher disease: mechanism and diagnostic implications. Acta Haematol. 2000; 104(2-3):103-5. Beutler E, Liebman H, Gelbart T, Stefanski E. PMID: 11154983.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    97. Kinetics of factor IX activity differ from that of factor IX antigen in patients with haemophilia B receiving high-purity factor IX replacement. Haemophilia. 1999 May; 5(3):174-80. Liebman HA, Rosenwald-Zuckerman T, Retzios A, Yasmin S, Kasper CK. PMID: 10444284.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    98. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology. 1998 Oct; 115(4):830-4. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam AL. PMID: 9753484.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    99. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden. Cancer. 1997 May 15; 79(10):2024-7. Weitz IC, Israel VK, Liebman HA. PMID: 9149031.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    100. Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance. Br J Haematol. 1996 Dec; 95(3):550-3. Liebman HA, Sutherland D, Bacon R, McGehee W. PMID: 8943900.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    101. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995 Jun 29; 332(26):1744-8. Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, Bernstein-Singer M, Espina BM, Cabral L, Allen S, et al. PMID: 7760890.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCTClinical Trials
    102. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. PMID: 7707129.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    103. Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology. 1993 Oct; 18(4):990-7. Weitz IC, Liebman HA. PMID: 8406374.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    104. pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo. Antimicrob Agents Chemother. 1993 Jul; 37(7):1480-7. Eron JJ, Chow YK, Caliendo AM, Videler J, Devore KM, Cooley TP, Liebman HA, Kaplan JC, Hirsch MS, D'Aquila RT. PMID: 7689822; PMCID: PMC187998.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    105. The metal-dependent conformational changes in factor IX associated with phospholipid binding. Studies using antibodies against a synthetic peptide and chemical modification of factor IX. Eur J Biochem. 1993 Mar 01; 212(2):339-45. Liebman HA. PMID: 7680311.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    106. Didanosine in the treatment of AIDS and AIDS-related complex: a critical appraisal of the dose and frequency of administration. Clin Infect Dis. 1993 Feb; 16 Suppl 1:S52-8. Liebman HA, Cooley TP. PMID: 8093847.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    107. Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus disease. Blood. 1992 Dec 15; 80(12):2969-76. Schacter LP, Rozencweig M, Beltangady M, Allan JD, Canetta R, Cooley TP, Dolin R, Kelley S, Lambert J, Liebman HA, et al. PMID: 1467512.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    108. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase. Am J Clin Pathol. 1992 Nov; 98(5):534-41. Liebman HA, Carfagno MK, Weitz IC, Berard P, Diiorio JM, Vosburgh E, Simms RW. PMID: 1485607.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    109. Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trials. Antimicrob Agents Chemother. 1992 Jun; 36(6):1280-3. Drusano GL, Yuen GJ, Morse G, Cooley TP, Seidlin M, Lambert JS, Liebman HA, Valentine FT, Dolin R. PMID: 1416828; PMCID: PMC190332.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    110. Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complex. J Clin Pharmacol. 1992 Mar; 32(3):242-7. Pai SM, Shukla UA, Grasela TH, Knupp CA, Dolin R, Valentine FT, McLaren C, Liebman HA, Martin RR, Pittman KA, et al. PMID: 1564128.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    111. A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer. Am J Hematol. 1991 Sep; 38(1):24-9. Liebman HA, Comenzo R, Allen ST, Dilorio JM. PMID: 1897511.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    112. Pulmonary Kaposi sarcoma in patients with AIDS: scintigraphic diagnosis with sequential thallium and gallium scanning. Radiology. 1991 Aug; 180(2):409-12. Lee VW, Fuller JD, O'Brien MJ, Parker DR, Cooley TP, Liebman HA. PMID: 2068302.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    113. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Ann Intern Med. 1991 Jul 15; 115(2):84-91. Gottlieb MS, Zackin RA, Fiala M, Henry DH, Marcel AJ, Combs KL, Vieira J, Liebman HA, Cone LA, Hillman KS, et al. PMID: 1676251.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    114. Subcutaneous Kaposi's sarcoma. Thallium scan demonstration. Clin Nucl Med. 1990 Aug; 15(8):569-71. Lee VW, Chen H, Panageas E, O'Keane JC, Liebman HA. PMID: 2390823.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    115. Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily. Rev Infect Dis. 1990 Jul-Aug; 12 Suppl 5:S552-60. Cooley TP, Kunches LM, Saunders CA, Perkins CJ, Kelley SL, McLaren C, McCaffrey RP, Liebman HA. PMID: 1974727.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    116. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med. 1990 May 10; 322(19):1340-5. Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA. PMID: 2139174.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    117. AIDS in intravenous drug users: issues related to enrollment in clinical trials. J Acquir Immune Defic Syndr (1988). 1990; 3 Suppl 2:S45-50. Craven DE, Liebman HA, Fuller J, Hagerty C, Cooley TP, Saunders CA, Steger KA, Libman H. PMID: 2231302.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    118. Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy)prothrombin. Cancer Res. 1989 Dec 01; 49(23):6493-7. Liebman HA. PMID: 2555045.
      View in: PubMed   Mentions: 13     Fields:    
    119. Increased T-cell colony formation in AIDS patients treated with zidovudine: a possible mechanism for increased lymphocyte number. AIDS. 1989 Sep; 3(9):605-7. Levy EM, Wu JM, Cohn SE, Liebman H, Black PH. PMID: 2506906.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    120. Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties. J Biol Chem. 1989 Jul 05; 264(19):11401-6. Ware J, Diuguid DL, Liebman HA, Rabiet MJ, Kasper CK, Furie BC, Furie B, Stafford DW. PMID: 2738071.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    121. AIDS-related Kaposi sarcoma: findings on thallium-201 scintigraphy. AJR Am J Roentgenol. 1988 Dec; 151(6):1233-5. Lee VW, Rosen MP, Baum A, Cohen SE, Cooley TP, Liebman HA. PMID: 3263778.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    122. The factor IX phospholipid-binding site is required for calcium-dependent activation of factor IX by factor XIa. J Biol Chem. 1987 Jun 05; 262(16):7605-12. Liebman HA, Furie BC, Furie B. PMID: 3108254.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    123. Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. Proc Natl Acad Sci U S A. 1986 Aug; 83(16):5803-7. Diuguid DL, Rabiet MJ, Furie BC, Liebman HA, Furie B. PMID: 3461460; PMCID: PMC386383.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    124. Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex. Proc Natl Acad Sci U S A. 1985 Jun; 82(11):3879-83. Liebman HA, Limentani SA, Furie BC, Furie B. PMID: 2408269; PMCID: PMC397892.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    125. Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy. Blood. 1984 Aug; 64(2):445-51. Furie B, Liebman HA, Blanchard RA, Coleman MS, Kruger SF, Furie BC. PMID: 6743826.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    126. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med. 1984 May 31; 310(22):1427-31. Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B. PMID: 6201741.
      View in: PubMed   Mentions: 173     Fields:    Translation:Humans
    127. Increased fibrinolysis and amyloidosis. Arch Intern Med. 1983 Apr; 143(4):678-82. Liebman H, Chinowsky M, Valdin J, Kenoyer G, Feinstein D. PMID: 6340622.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    128. Severe depression of antithrombin III associated with disseminated intravascular coagulation in women with fatty liver of pregnancy. Ann Intern Med. 1983 Mar; 98(3):330-3. Liebman HA, McGehee WG, Patch MJ, Feinstein DI. PMID: 6830076.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    129. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin. Cancer. 1983 Feb 15; 51(4):681-5. Sandler RM, Liebman HA, Patch MJ, Teitelbaum A, Levine AM, Feinstein DI. PMID: 6571800.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    130. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood. 1983 Jan; 61(1):92-8. Levine AM, Forman SJ, Meyer PR, Koehler SC, Liebman H, Paganini-Hill A, Pockros A, Lukes RJ, Feinstein DI. PMID: 6600214.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    131. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin. Cancer. 1982 Nov 15; 50(10):2106-10. Sandler RM, Liebman HA, Patch MJ, Teitelbaum A, Levine AM, Feinstein DI. PMID: 6957257.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    132. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase. Cancer. 1982 Aug 01; 50(3):451-6. Liebman HA, Wada JK, Patch MJ, McGehee W. PMID: 7046902.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    133. Hepatic vitamin K-dependent carboxylation of blood-clotting proteins. Hepatology. 1982 Jul-Aug; 2(4):488-94. Liebman HA, Furie BC, Furie B. PMID: 7095749.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Howard's Networks
    Concepts (485)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (29)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.